During the past decade, Healthy Brain Aging Labs Uni of Calgary conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Healthy Brain Aging Labs Uni of Calgary" #1 collaborator was "Anavex Australia Pty Ltd." with 2 trials as a collaborator, "Anavex Germany GmbH" with 2 trials as a collaborator and "Anavex Canada Ltd." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Healthy Brain Aging Labs Uni of Calgary" are "Alzheimer Disease" (2 trials). Many other conditions were trialed in "Healthy Brain Aging Labs Uni of Calgary" in a lesser frequency.

Most popular intervention types in "Healthy Brain Aging Labs Uni of Calgary" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "ANAVEX2-73" (1 trials), "High dose ANAVEX2-73" (1 trials), "Mid dose ANAVEX2-73" (1 trials) and "Placebo oral capsule" (1 trials). Other intervention names were less common.

The vast majority of trials in "Healthy Brain Aging Labs Uni of Calgary" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Healthy Brain Aging Labs Uni of Calgary". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Healthy Brain Aging Labs Uni of Calgary, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Healthy Brain Aging Labs Uni of Calgary, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".